Figure 10.
Proposed mechanisms by which Tollip regulates type 2 inflammation during influenza A virus (IAV) infection. Tollip deficiency enhances the release of ATP in lungs exposed to allergens and viruses. ATP binds to its receptor P2Y13 on epithelial cells, leading to IL-33 release. IL-33 binds to ST2L on different cell types, and results in type 2 cytokine release. Blocking ATP and IL-33 signaling by MRS2211 and sST2 attenuates excessive type 2 inflammation during IAV infection in Tollip deficient lungs. AT1; alveolar type I cell, AT2; alveolar type II cell. Created with BioRender.com. Tollip structure was extracted from protein data bank (www.rcsb.org).